• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤溶酶原激活物抑制剂-1反应形式的模型。

A model of the reactive form of plasminogen activator inhibitor-1.

作者信息

Aertgeerts K, De Bondt H L, De Ranter C, Declerck P J

机构信息

Laboratorium voor Analytische Chemie en Medicinale Fysicochemie, Katholieke Universiteit Leuven, Belgium.

出版信息

J Struct Biol. 1994 Nov-Dec;113(3):239-45. doi: 10.1006/jsbi.1994.1058.

DOI:10.1006/jsbi.1994.1058
PMID:7734247
Abstract

A model of the reactive form of plasminogen activator inhibitor-1 (PAI-1) has been constructed using molecular graphics and starting from the known crystal structure of latent PAI-1. The residues P16 to P10', of which P16-P4 form strand 4 of the beta-sheet A (s4A) and P3-P10' form an extended loop in the latent form, have been removed and remodeled into this structure, based on the structures of ovalbumin and cleaved alpha 1-proteinase inhibitor. Residues P4'-P10' were remodeled as a beta-strand s1C, located on the surface of the molecule and the N-terminal end (P16-P14) of the eliminated loop was rebuilt using appropriate backbone dihedrals. Subsequently, a secondary structure prediction program was applied and further optimization of the model was performed by several molecular dynamics runs. Apparently the beta-strand was stabilized by only two hydrogen bonds. Further analysis revealed that, although s4A was removed, s3A and s5A did not approach each other. In this current model it was also found that the large gap between the loop connecting s4C-s3C and the loop connecting s3B-hG remained 11 A in contrast to the small gap (4A) at a similar position in other serpins. These observations may explain the ease of a conformational change of the reactive site loop of PAI-1 during transition to the latent and the preinserted form. In addition the current model can be used for the design of stable, functional, PAI-1 mutants. Detailed structural analysis of the latter may facilitate studies on the structure-function relationship in PAI-1 in particular and in other serpins in general.

摘要

已利用分子图形技术并从潜在纤溶酶原激活物抑制剂-1(PAI-1)的已知晶体结构出发构建了PAI-1反应形式的模型。基于卵清蛋白和裂解的α1-蛋白酶抑制剂的结构,去除了P16至P10'残基(其中P16 - P4形成β-折叠A的链4(s4A),P3 - P10'在潜在形式中形成一个延伸环),并将其重新构建到该结构中。P4' - P10'残基被重新构建为位于分子表面的β-链s1C,消除环的N末端(P16 - P14)使用合适的主链二面角进行了重建。随后,应用了二级结构预测程序,并通过多次分子动力学运行对模型进行了进一步优化。显然,该β-链仅通过两个氢键得以稳定。进一步分析表明,尽管s4A被去除,但s3A和s5A并未相互靠近。在当前模型中还发现,连接s4C - s3C的环与连接s3B - hG的环之间的大间隙保持为11埃,而在其他丝氨酸蛋白酶抑制剂的类似位置则为小间隙(4埃)。这些观察结果可能解释了PAI-1反应位点环在向潜在形式和预插入形式转变过程中构象变化的容易程度。此外,当前模型可用于设计稳定、有功能的PAI-1突变体。对后者的详细结构分析可能有助于特别是对PAI-1以及一般其他丝氨酸蛋白酶抑制剂的结构-功能关系的研究。

相似文献

1
A model of the reactive form of plasminogen activator inhibitor-1.纤溶酶原激活物抑制剂-1反应形式的模型。
J Struct Biol. 1994 Nov-Dec;113(3):239-45. doi: 10.1006/jsbi.1994.1058.
2
Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.纤溶酶原激活物抑制剂1。天然丝氨酸蛋白酶抑制剂的结构,与其他构象的比较及其对丝氨酸蛋白酶抑制剂失活的影响。
J Mol Biol. 2000 Mar 31;297(3):683-95. doi: 10.1006/jmbi.2000.3604.
3
Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.L-抗凝血酶的制备性诱导与表征:潜在纤溶酶原激活物抑制剂-1的结构同源物
Biochemistry. 1997 Oct 21;36(42):13133-42. doi: 10.1021/bi970664u.
4
Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.纤溶酶原激活物抑制剂-1的底物行为与反应位点环插入缺失无关。
Biochemistry. 1996 Jun 11;35(23):7474-81. doi: 10.1021/bi960079d.
5
Specific interactions of serpins in their native forms attenuate their conformational transitions.丝氨酸蛋白酶抑制剂(serpins)天然形式下的特异性相互作用会减弱其构象转变。
Protein Sci. 2007 Aug;16(8):1659-66. doi: 10.1110/ps.072838107. Epub 2007 Jun 28.
6
Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.纤溶酶原激活物抑制剂-1处于活性构象并在结合配体时聚合,从而中和其活性。
Int J Mol Med. 2006 Mar;17(3):437-47.
7
Comparative analysis of the proteinase specificity in wild-type and stabilized plasminogen activator inhibitor-1: evidence for contribution of intramolecular flexibility.野生型和稳定型纤溶酶原激活物抑制剂-1中蛋白酶特异性的比较分析:分子内柔韧性作用的证据
Biochem Biophys Res Commun. 2004 Aug 27;321(3):746-51. doi: 10.1016/j.bbrc.2004.07.023.
8
Structural basis for serpin inhibitor activity.丝氨酸蛋白酶抑制剂(serpin)抑制活性的结构基础。
Proteins. 1995 Jul;22(3):210-25. doi: 10.1002/prot.340220303.
9
Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.凝血酶与纤溶酶原激活物抑制剂-1反应缓慢的结构基础解析。
Biochemistry. 1998 Sep 22;37(38):13138-42. doi: 10.1021/bi9808518.
10
Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.通过定点诱变鉴定1型纤溶酶原激活物抑制剂低分子量抑制剂的结合位点。
Biochemistry. 1998 Feb 3;37(5):1227-34. doi: 10.1021/bi971554q.

引用本文的文献

1
Dissection of the Ovulatory Process Using Approaches.使用多种方法剖析排卵过程。
Front Cell Dev Biol. 2020 Dec 9;8:605379. doi: 10.3389/fcell.2020.605379. eCollection 2020.
2
Ovulation: Parallels With Inflammatory Processes.排卵:与炎症过程的相似性。
Endocr Rev. 2019 Apr 1;40(2):369-416. doi: 10.1210/er.2018-00075.
3
Extending the capabilities of targeted molecular dynamics: simulation of a large conformational transition in plasminogen activator inhibitor 1.拓展靶向分子动力学的能力:纤溶酶原激活物抑制剂1中大构象转变的模拟
Protein Sci. 2001 Apr;10(4):798-808. doi: 10.1110/ps.40401.
4
Plasminogen Activator Inhibitor 1: Molecular Aspects and Clinical Importance.纤溶酶原激活物抑制剂1:分子层面及临床意义
J Thromb Thrombolysis. 1995;2(3):187-193. doi: 10.1007/BF01062709.
5
Functional effects of single amino acid substitutions in the region of Phe113 to Asp138 in the plasminogen activator inhibitor 1 molecule.纤溶酶原激活物抑制剂1分子中苯丙氨酸113至天冬氨酸138区域单个氨基酸取代的功能效应。
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):409-15. doi: 10.1042/bj3310409.
6
Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.尿激酶型纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物与内吞作用受体α2-巨球蛋白受体/低密度脂蛋白受体相关蛋白及极低密度脂蛋白受体的结合涉及抑制剂中的碱性残基。
Biochem J. 1998 Jan 1;329 ( Pt 1)(Pt 1):55-63. doi: 10.1042/bj3290055.